The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
Open accessAbstract
Our primary objective was to investigate a biomarker driven model for the interrelationships between vascular disease pathology, amyloid pathology, and longitudinal cognitive decline in cognitively normal elderly subjects between 70 and 90 years of age. Our secondary objective was to investigate the beneficial effect of cognitive reserve on these interrelationships. We used brain amyloid-β load measured using Pittsburgh compound B positron emission tomography as a marker for amyloid pathology. White matter hyperintensities and brain infarcts were measured using fluid-attenuated inversion recovery magnetic resonance imaging as a marker for vascular pathology. We studied 393 cognitively normal elderly participants in the population-based Mayo Clinic Study of Aging who had a baseline 3 T fluid-attenuated inversion recovery magnetic resonance imaging assessment, Pittsburgh compound B positron emission tomography scan, baseline cognitive assessment, lifestyle measures, and at least one additional clinical follow-up. We classified subjects as being on the amyloid pathway if they had a global cortical amyloid-β load of ≥1.5 standard uptake value ratio and those on the vascular pathway if they had a brain infarct and/or white matter hyperintensities load ≥1.11% of total intracranial volume (which corresponds to the top 25% of white matter hyperintensities in an independent non-demented sample). We used a global cognitive z-score as a measure of cognition. We found no evidence that the presence or absence of vascular pathology influenced the presence or absence of amyloid pathology and vice versa, suggesting that the two processes seem to be independent. Baseline cognitive performance was lower in older individuals, in males, those with lower education/occupation, and those on the amyloid pathway. The rate of cognitive decline was higher in older individuals (P < 0.001) and those with amyloid (P = 0.0003) or vascular (P = 0.0037) pathologies. In those subjects with both vascular and amyloid pathologies, the effect of both pathologies on cognition was additive and not synergistic. For a 79-year-old subject, the predicted annual rate of global z-score decline was -0.02 if on neither pathway, -0.07 if on the vascular pathway, -0.08 if on the amyloid pathway and -0.13 if on both pathways. The main conclusions of this study were: (i) amyloid and vascular pathologies seem to be at least partly independent processes that both affect longitudinal cognitive trajectories adversely and are major drivers of cognitive decline in the elderly; and (ii) cognitive reserve seems to offset the deleterious effect of both pathologies on the cognitive trajectories.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many patients with MCI or dementia have mixed pathologies. 48,49,96,97”
From Vascular Cognitive Impairment (2017) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“WMHs and Aβ are also key drivers of cognitive decline in healthy older adults, and both are considered biomarkers of preclinical dementia [6,7].”
From Amyloid-PET and White Matter Hyperintensities Have Independent Effects on Baseline Cognitive Function and Synergistic Effects on Longitudinal Executive Function (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Third, there are interindividual variations in the ability to compensate for both vascular and neurodegenerative pathologies. 49-51”
From Vascular Cognitive Impairment (2017) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“These findings shed mechanistic light on clinical studies suggesting that vascular pathology is independent of, but additive to, Aβ load in mediating cognitive decline (Rabin et al., 2018; Vemuri et al., 2015).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Vemuri et al., 2015
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [49]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citationGauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Self-citationAdvancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Self-citationFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Jack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958 · cited 1×
“All PET quantitative image analysis including quality control were performed at the Mayo Clinic using the same fully automated image processing pipeline as described previously (Jack et al., 2008; Senjem et al., 2008).”
MethodSelf-citationBrain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846
Roberts, R. O., Geda, Y. E., Knopman, D. S., Cha, R. H., Pankratz, V. S., Boeve, B. F., Ivnik, R. J., Tangalos, E. G., Petersen, R. C., & Rocca, W. A. (2008) · Neuroepidemiology · doi:10.1159/000115751 · Cited by 793
Self-citationRocca, W. A., Yawn, B. P., St. Sauver, J. L., Grossardt, B. R., & Melton, L. J. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.012 · Cited by 791
Self-citationPrevalence of mild cognitive impairment is higher in men: The Mayo Clinic Study of Aging
Petersen, R. C., Roberts, R. O., Knopman, D. S., Geda, Y. E., Cha, R. H., Pankratz, V. S., Boeve, B. F., Tangalos, E. G., Ivnik, R. J., & Rocca, W. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f11d85 · Cited by 738
Self-citationBrain Infarction and the Clinical Expression of Alzheimer Disease-Reply
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020046024 · Cited by 674
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley–Whyte, E. T., Frosch, M. P., Albert, M. S., Hyman, B. T., & Irizarry, M. C. (2004) · Neurology · doi:10.1212/01.wnl.0000115115.98960.37 · Cited by 666
Vascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664 · cited 1×
“There is a suggested interrelationship between the presence of cerebrovascular disease and Alzheimer’s disease pathophysiology because dementia due to these pathologies shares several of the same risk factors, which include dia- betes, hypertension, stroke and cholesterol (Breteler, 2000).”
BackgroundSt. Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., & Rocca, W. A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq482 · Cited by 649
Self-citationData Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system
St Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., Pankratz, J. J., Brue, S. M., & Rocca, W. A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys195 · Cited by 613
Self-citationThe overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557 · cited 3×
“Synergistic effects of cerebrovascular disease and Alzheimer’s disease, as suggested by Iadecola (2010), would mean that the impact of cerebrovascular disease and Alzheimer’s disease on cognitive decline is worse through an interaction (arrow C in Fig.”
BackgroundLopresti, B. J., Klunk, W. E., Mathis, C. A., Hoge, J. A., Ziolko, S. K., Lu, X., MELTZER, C. C., Schimmel, K., Tsopelas, N. D., DeKosky, S. T., et al. (2005) · PubMed · Cited by 543
DeCarli, C., Murphy, D. G. M., Tranh, M., Grady, C. L., Haxby, J. V., Gillette, J. A., Salerno, J. A., Gonzales-Aviles, A., Honvitz, B., Rapoport, S. I., et al. (1995) · Neurology · doi:10.1212/wnl.45.11.2077 · Cited by 531
The role of cerebral ischemia in Alzheimer’s disease
Kalaria, R. N. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00125-1 · Cited by 521
Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study
Ahtiluoto, S., Polvikoski, T., Peltonen, M., Solomon, A., Tuomilehto, J., Winblad, B., Sulkava, R., & Kivipelto, M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f4d7f8 · Cited by 482
Vascular risk factors and dementia: How to move forward?
Viswanathan, A., Rocca, W. A., & Tzourio, C. (2009) · Neurology · doi:10.1212/01.wnl.0000341271.90478.8e · Cited by 414
Self-citationThe Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts
Schneider, J. A., Aggarwal, N. T., Barnes, L., Boyle, P., & Bennett, D. A. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1227 · Cited by 372
Brain Infarction and the Clinical Expression of Alzheimer Disease
Roman, G. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020045023 · Cited by 350
van Hooren, S. A. H., Valentijn, A. M., Bosma, H., Ponds, R. W. H. M., van Boxtel, M. P. J., & Jolles, J. (2007) · Aging, Neuropsychology, and Cognition · doi:10.1080/138255890969483 · Cited by 344
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
Gurol, M. E., Irizarry, M. C., Smith, E. E., Raju, S., Diaz-Arrastia, R., Bottiglieri, T., Rosand, J., Growdon, J. H., & Greenberg, S. M. (2006) · Neurology · doi:10.1212/01.wnl.0000191403.95453.6a · Cited by 339 · cited 1×
“…that the presence of vascular risk factors may increase the risk of Alzheimer’s disease (Kalaria, 2000; Viswanathan et al., 2009; de la Torre, 2010) and subjects with Alzheimer’s disease are at increased risk of cerebrovascular disease (Gurol et al., 2006; Gomis et al., 2009; Iadecola, 2010).”
BackgroundMeta-analysis of amyloid-cognition relations in cognitively normal older adults
Hedden, T., Oh, H., Younger, A. P., & Patel, T. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828ab35d · Cited by 319
Relation of cerebral infarctions to dementia and cognitive function in older persons
Schneider, J. A., Wilson, R. S., Cochran, E. J., Bienias, J. L., Arnold, S. E., Evans, D. A., & Bennett, D. A. (2003) · Neurology · doi:10.1212/01.wnl.0000055863.87435.b2 · Cited by 305
Weller, R. O., Boche, D., & Nicoll, J. A. R. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0498-z · Cited by 297 · cited 2×
“…pathophysiology on cognition will need to account for the presence and severity of cerebrovascular disease because cerebrovascular disease worsens the clinical expression of Alzheimer’s disease pathophysiology (Nagy et al., 1997; Snowdon et al., 1997; Zekry et al., 2002; Weller et al., 2009).”
BackgroundLife-span cognitive activity, neuropathologic burden, and cognitive aging
Wilson, R. S., Boyle, P. A., Yu, L., Barnes, L. L., Schneider, J. A., & Bennett, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c5e8a · Cited by 296
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [ 11 C]PiB
Resnick, S. M., Sojkova, J., Zhou, Y., An, Y., Ye, W., Holt, D. P., Dannals, R. F., Mathis, C. A., Klunk, W. E., Ferrucci, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d3e3e9 · Cited by 288
Diabetes is related to cerebral infarction but not to AD pathology in older persons
Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Li, Y., Arnold, S. E., Wang, Z., & Bennett, D. A. (2006) · Neurology · doi:10.1212/01.wnl.0000247053.45483.4e · Cited by 281
Gouw, A. A., Seewann, A., Vrenken, H., van der Flier, W. M., Rozemuller, J. M., Barkhof, F., Scheltens, P., & Geurts, J. J. G. (2008) · Brain · doi:10.1093/brain/awn265 · Cited by 281
White matter hyperintensities and cognition: Testing the reserve hypothesis
Brickman, A. M., Siedlecki, K. L., Muraskin, J., Manly, J. J., Luchsinger, J. A., Yeung, L.-K., Brown, T. R., DeCarli, C., & Stern, Y. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.013 · Cited by 266
The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic Study of Aging
Roberts, R. O., Geda, Y. E., Knopman, D. S., Cha, R. H., Pankratz, V. S., Boeve, B. F., Tangalos, E. G., Ivnik, R. J., Rocca, W. A., & Petersen, R. C. (2012) · Neurology · doi:10.1212/wnl.0b013e3182452862 · Cited by 265
Self-citationVascular health and longitudinal changes in brain and cognition in middle-aged and older adults.
Raz, N., Rodrigue, K. M., Kennedy, K. M., & Acker, J. D. (2007) · Neuropsychology · doi:10.1037/0894-4105.21.2.149 · Cited by 262
Shapira, I. L. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0118 · Cited by 233
Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of aging cohort
Dolan, H., Crain, B., Troncoso, J., Resnick, S. M., Zonderman, A. B., & Obrien, R. J. (2010) · Annals of Neurology · doi:10.1002/ana.22055 · Cited by 231
AD lesions and infarcts in demented and non‐demented Japanese‐American men
Petrovitch, H., Ross, G. W., Steinhorn, S. C., Abbott, R. D., Markesbery, W., Davis, D., Nelson, J., Hardman, J., Masaki, K., Vogt, M. R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20318 · Cited by 230 · cited 1×
“…burden based on pathological criteria by assuming that the percentage of non-demented subjects with vascular disease in our population is about 33% based on existing published autopsy studies with similar populations (Schneider et al., 2003; Petrovitch et al., 2005; Longstreth et al., 2009).”
BackgroundThe Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease
NAGY, Z., ESIRI, M. M., JOBST, K. A., MORRIS, J. H., -F. KING, E. M., MCDONALD, B., JOACHIM, C., LITCHFIELD, S., BARNETSON, L., & SMITH, A. D. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00007 · Cited by 218
White, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1178 · Cited by 193
Effect of lifestyle activities on alzheimer disease biomarkers and cognition
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Roberts, R. O., Lowe, V. J., Kantarci, K., Senjem, M. L., Gunter, J. L., Boeve, B. F., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23665 · Cited by 193
Self-citationComparison of 18F-FDG and PiB PET in Cognitive Impairment
Lowe, V. J., Kemp, B. J., Jack, C. R., Senjem, M., Weigand, S., Shiung, M., Smith, G., Knopman, D., Boeve, B., Mullan, B., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058529 · Cited by 192
Self-citationCognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
Vemuri, P., Weigand, S. D., Przybelski, S. A., Knopman, D. S., Smith, G. E., Trojanowski, J. Q., Shaw, L. M. J., DeCarli, C. S., Carmichael, O. T., Bernstein, M. A., et al. (2011) · Brain · doi:10.1093/brain/awr049 · Cited by 185
Self-citationDegenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly
Zekry, D., Duyckaerts, C., Moulias, R., Belmin, J., Geoffre, C., Herrmann, F., & Hauw, J.-J. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0493-5 · Cited by 184
Jellinger, K. A. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.09.002 · Cited by 179
Gender and education impact on brain aging: A general cognitive factor approach.
Proust‐Lima, C., Amieva, H., Letenneur, L., Orgogozo, J., Jacqmin‐Gadda, H., & Dartigues, J. (2008) · Psychology and Aging · doi:10.1037/a0012838 · Cited by 176
Machulda, M. M., Pankratz, V. S., Christianson, T. J. H., Ivnik, R. J., Mielke, M. M., Roberts, R. O., Knopman, D. S., Boeve, B. F., & Petersen, R. C. (2013) · The Clinical Neuropsychologist · doi:10.1080/13854046.2013.836567 · Cited by 175
Self-citationCognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
Pike, K. E., Ellis, K. A., Villemagne, V. L., Good, N. M., Chételat, G., Ames, D. J., Szoeke, C. E. I., Laws, S. M., Verdile, G., Martins, R. N., et al. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.04.012 · Cited by 171
Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy Study
Launer, L. J., Hughes, T. M., & White, L. R. (2011) · Annals of Neurology · doi:10.1002/ana.22520 · Cited by 171
Gurol, M. E., Viswanathan, A., Gidicsin, C., Hedden, T., Martinez-Ramirez, S., Dumas, A., Vashkevich, A., Ayres, A. M., Auriel, E., van Etten, E., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23830 · Cited by 159
The Vascular Hypothesis of Alzheimer’s Disease: Bench to Bedside and Beyond
de la Torre, J. C. (2010) · Neurodegenerative Diseases · doi:10.1159/000285520 · Cited by 159
Vascular burden and Alzheimer disease pathologic progression
Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b9d · Cited by 156
Self-citationChui, H. C., Zheng, L., Reed, B., Vinters, H. V., & Mack, W. J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt98 · Cited by 156
Pathologies and Pathological Mechanisms for White Matter Hyperintensities in Depression
Thomas, A. J., Perry, R., Barber, R., Kalaria, R. N., & O'Brien, J. T. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04835.x · Cited by 144
Engaging in Cognitive Activities, Aging, and Mild Cognitive Impairment: A Population-Based Study
Geda, Y. E., Topazian, H. M., Lewis, R. A., Roberts, R. O., Knopman, D. S., Pankratz, V. S., Christianson, T. J. H., Boeve, B. F., Tangalos, E. G., Ivnik, R. J., et al. (2011) · Journal of Neuropsychiatry · doi:10.1176/jnp.23.2.jnp149 · Cited by 144
Self-citationCerebrovascular disease, beta-amyloid, and cognition in aging
Marchant, N. L., Reed, B. R., DeCarli, C. S., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.001 · Cited by 127 · cited 3×
“Our findings of an additive effect are consistent with cross- sectional biomarker studies that have suggested that the effect of both pathologies are additive on cognitive performance (Launer et al., 2008, 2011; Lo and Jagust, 2012; Marchant et al., 2012).”
BackgroundResultKozachuk, W. E., DeCarli, C., Schapiro, M. B., Wagner, E. E., Rapoport, S. I., & Horwitz, B. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120050009 · Cited by 126
Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study
Riekse, R. G., Leverenz, J. B., McCormick, W. C., Bowen, J. D., Teri, L. L., Nochlin, D., Simpson, K., Eugenio, C. J., Larson, E. B., & Tsuang, D. W. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52405.x · Cited by 122
MRI and MRS predictors of mild cognitive impairment in a population-based sample
Kantarci, K., Weigand, S. D., Przybelski, S. A., Preboske, G. M., Pankratz, V. S., Vemuri, P., Senjem, M. L., Murphy, M. C., Gunter, J. L., Machulda, M. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829a3329 · Cited by 119
Self-citationAD brain pathology: Vascular origins?
Launer, L. J., Petrovitch, H., Ross, G. W., Markesbery, W., & White, L. R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.008 · Cited by 117
Murray, M. E., Vemuri, P., Preboske, G. M., Murphy, M. C., Schweitzer, K. J., Parisi, J. E., Jack, C. R., & Dickson, D. W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318277387e · Cited by 107
Self-citationThe aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction
Marchant, N. L., Reed, B. R., Sanossian, N., Madison, C. M., Kriger, S., Dhada, R., Mack, W. J., DeCarli, C., Weiner, M. W., Mungas, D. M., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.405 · Cited by 106
A neuropathological study of periventricular white matter hyperintensities in major depression
Thomas, A. J., O'Brien, J. T., Barber, R., McMeekin, W., & Perry, R. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00064-2 · Cited by 103
Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women
Raz, L., Jayachandran, M., Tosakulwong, N., Lesnick, T. G., Wille, S. M., Murphy, M. C., Senjem, M. L., Gunter, J. L., Vemuri, P., Jack, C. R., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840c9f · Cited by 101
Self-citationCognitive function in the oldest old: women perform better than men
van Exel, E. R., Gussekloo, J., de Craen, A. J., der Wiel, A. B.-V., Houx, P., Knook, D. L., & Westendorp, R. G. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.1.29 · Cited by 99
Understanding the pathology of vascular cognitive impairment
Jellinger, K. A. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.029 · Cited by 94
Failure to Modulate Attentional Control in Advanced Aging Linked to White Matter Pathology
Hedden, T., Dijk, K. R. A. V., Shire, E. H., Sperling, R. A., Johnson, K., & Buckner, R. L. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr172 · Cited by 89
Kantarci, K., Petersen, R. C., Przybelski, S. A., Weigand, S. D., Shiung, M. M., Whitwell, J. L., Negash, S., Ivnik, R. J., Boeve, B. F., Knopman, D. S., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1621 · Cited by 84
Self-citationBlood Pressure and Brain Injury in Older Adults: Findings from a Community‐Based Autopsy Study
Wang, L. Y., Larson, E. B., Sonnen, J. A., Shofer, J. B., McCormick, W. C., Bowen, J. D., Montine, T. J., & Li, G. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02493.x · Cited by 72
Predicting cognitive change in older adults: the relative contribution of practice effects.
Duff, K., Beglinger, L., Moser, D., Paulsen, J. S., Schultz, S., & Arndt, S. (2010) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acp105 · Cited by 72
Terminal decline and practice effects in older adults without dementia: The MoVIES project
Dodge, H. H., Wang, C.-N., Chang, C.-C. H., & Ganguli, M. (2011) · Neurology · doi:10.1212/wnl.0b013e31822b0068 · Cited by 69
Longstreth, W. T., Sonnen, J. A., Koepsell, T. D., Kukull, W. A., Larson, E. B., & Montine, T. J. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318199fc7a · Cited by 61
Alzheimer's disease with and without cerebral infarcts
del Ser, T., Hachinski, V., Merskey, H., & Muñoz, D. G. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.08.016 · Cited by 60
Hickman, S. E., Howieson, D. B., Dame, A., Sexton, G. J., & Kaye, J. A. (2000) · Developmental Neuropsychology · doi:10.1207/s15326942dn1703_3 · Cited by 57
Plasma β-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype
Gomis, M., Sobrino, T., Ois, A., Millán, M., Rodríguez-Campello, A., de la Ossa, N. P., Rodríguez-González, R., Jiménez-Conde, J., Cuadrado-Godia, E., Roquer, J., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.559641 · Cited by 52
Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.
Salmon, D. P., Ferris, S. H., Thomas, R. G., Sano, M., Cummings, J. L., Sperling, R. A., Petersen, R. C., & Aisen, P. S. (2013) · Neuropsychology · doi:10.1037/a0032707 · Cited by 32
Self-citationNichols, M., Meador, K. J., Loring, D. W., Poon, L. W., Clayton, G. M., & Martin, P. (1994) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879400700101 · Cited by 18
Cognitive Function in the Oldest Old: Women Perform Better Than Men
van Exel, E. R., Gussekloo, J., de Craen, A. J. M., et al. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200201000-00021 · Cited by 8
Research works printed but not linked: 1
- Senjem, 2008, Automated ROI analysis of 11C Pittsburgh compound B images using structural magnetic resonance imaging atlases, Alzheimer's and Dementia. Alzheimer's Association International Conference on Alzheimer's Disease
Cited by
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
Self-citationThe Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Self-citationSex differences in Alzheimer disease — the gateway to precision medicine
for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Coresh, J., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.3090 · Cited by 650
“stroke risk score has beenmost strongly associated with cognition in individualswithout increasedADneuropathologyon autopsy,(31) and in the Alzheimer DiseaseNeuroimaging Initiative, amyloid andvascular pathology acted additively andnot synergistically, and independently of one another, in increasing association with c…”
BackgroundSelf-citation
Metadata
- Authors
- Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Preboske, G. M., Kantarci, K., Raman, M. R., Machulda, M. M., Mielke, M. M., Lowe, V. J., Senjem, M. L., Gunter, J. L., Rocca, W. A., Roberts, R. O., Petersen, R. C., & Jack, C. R.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Vemuri, Prashanthi
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-13
- Volume
- 138
- Issue
- 3
- Pages
- 761-771
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC4339775
- OpenAlex
- W2096197732
- Cited by
- 299
- References
- 80
- Citations by year
- 2026: 22 · 2025: 19 · 2024: 23 · 2023: 20 · 2022: 30 · 2021: 22 · 2020: 35 · 2019: 31 · 2018: 33 · 2017: 25 · 2016: 31 · 2015: 7
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000135)
- National Institute on Aging (R01AG034676, U01AG006786, K99AG037573, R01AG011378, R01AG041851, R00AG037573, P50AG016574)
- National Center for Research Resources (C06RR018898)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- cognitive decline, amyloid pathology, vascular pathology, white matter hyperintensities, cerebral infarction, cognitive reserve, Pittsburgh compound B, FLAIR, cognitively normal elderly, Mayo Clinic Study of Aging, biomarkers, brain aging, education and cognition, sex differences in cognition
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Analysis of Variance, Aniline Compounds, Cerebrovascular Disorders, Cognition Disorders, Female, Humans, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Predictive Value of Tests, Thiazoles, Tomography Scanners, X-Ray Computed, Amyloid beta-Peptides, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.